Cultural Industries 06 May 2020 Telethon Kids Institute to lead COVID-19 drug trial Bookmark Save articles for future reference. Subscribe to BN Log In Share to Facebook X LinkedIn Telethon Kids Institute has received $2.66 million from BHP to lead a trial testing the effectiveness of multiple sclerosis drug interferon in reducing the infectiousness of COVID-19 patients.
